Cancer death rates in the United States have declined to 25 percent (2.1 million) between 1991 and 2014. This is due to steady reductions in smoking, advances in early detection and treatment, says a new report.
According to 'Cancer Statistics 2017' annual report of the American Cancer Society, the cancer death rate dropped from its peak of 215.1 (per 100,000 population) in 1991 to 161.2 (per 100,000 population) in 2014.
Cancer Deaths to be Eliminated by 2050, Except for Over-80s
Cancer deaths will be eliminated for all except for the people over 80 years of age by 2050, reveals a new study.
Advertisement
‘The death rates decreased for the four major cancer sites: lung, breast, prostate and colorectal cancer.’
Tweet it Now
The death rates decreased for the four major cancer sites: lung (-43 percent between 1990 and 2014 among males and -17 percent between 2002 and 2014 among females), breast (-38 percent from 1989 to 2014), prostate (-51 percent from 1993 to 2014) and colorectal (-51 percent from 1976 to 2014).
"The continuing drops in the cancer death rate are a powerful sign of the potential we have to reduce cancer's deadly toll," said Otis W. Brawley, Chief Medical Officer of the American Cancer Society.
![Older People With Memory and Thinking Problems May Have Lower Risk of Cancer Death]( "Older People With Memory and Thinking Problems May Have Lower Risk of Cancer Death")
Older people who have memory and thinking problems, but do not yet have dementia may have a lower risk of dying from cancer than people who have no memory and thinking problems.
While the overall cancer incidence rate was stable in women and declined by about two per cent per year in men, the cancer death rate decreased by about 1.5 percent annually in both men and women.
In addition, the report found significant gender disparities -- the cancer incidence rate is 20 percent higher in men than in women, while the cancer death rate is 40 percent higher in men.
Liver cancer -- a highly fatal cancer -- was found to be three times more common in men than in women.
While the incidence and death rates of cancers of the esophagus, larynx and bladder, were found to be about four-fold higher in men, the incidence rates of melanoma -- skin cancer -- were about 60 percent higher in men than in women and death rates were more than double in men compared with women, the researchers stated.
The report was published in CA: A Cancer Journal for Clinicians.
Source: IANS
Older People With Memory and Thinking Problems May Have Lower Risk of Cancer Death
Older people who have memory and thinking problems, but do not yet have dementia may have a lower risk of dying from cancer than people who have no memory and thinking problems.
Advertisement
While the overall cancer incidence rate was stable in women and declined by about two per cent per year in men, the cancer death rate decreased by about 1.5 percent annually in both men and women.
In addition, the report found significant gender disparities -- the cancer incidence rate is 20 percent higher in men than in women, while the cancer death rate is 40 percent higher in men.
Liver cancer -- a highly fatal cancer -- was found to be three times more common in men than in women.
While the incidence and death rates of cancers of the esophagus, larynx and bladder, were found to be about four-fold higher in men, the incidence rates of melanoma -- skin cancer -- were about 60 percent higher in men than in women and death rates were more than double in men compared with women, the researchers stated.
The report was published in CA: A Cancer Journal for Clinicians.
Source: IANS
New 'Fluid Biopsy' Could Help Reduce Cancer Deaths
A new test developed by scientists could help could help save thousands of cancer victims per year.
Advertisement
 Children's Cancer Death Rates Drop by 24 Percent in the Last Decade in UKThe rate of children dying from cancer has dropped by 24% in the last decade, says a new report by Cancer Research UK. | Advertisement
|
Advertisement
Recommended Reading
Latest Cancer News
The mouse avatars created help study and develop personalized treatments against blood cancer - myeloma.
Chronotherapy (the sleep-wake cycle) is observed as a valuable alternative treatment in cancer diagnosis and treatment.
A nanoengineering platform targets neutrophils, the white blood cells without killing pancreatic cancer cells paving the way for effective treatments.
The mechanism by which the kinases cause inflammation has been discovered by scientists.
Pancreatic cancer cases are on the rise. The biomarker approach could reduce the chance of developing pancreatic cancer.